News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
323,567 Results
Type
Article (16837)
Company Profile (106)
Press Release (306615)
Multimedia
Podcasts (67)
Webinars (13)
Section
Business (103592)
Career Advice (494)
Deals (18244)
Drug Delivery (77)
Drug Development (44599)
Employer Resources (55)
FDA (8685)
Job Trends (7154)
News (178110)
Policy (16456)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (540)
Accelerated approval (18)
Adcomms (10)
Allergies (86)
Alliances (27646)
ALS (97)
Alzheimer's disease (685)
Antibody-drug conjugate (ADC) (168)
Approvals (9012)
Artificial intelligence (299)
Autoimmune disease (79)
Automation (18)
Bankruptcy (160)
Best Places to Work (5228)
BIOSECURE Act (9)
Biosimilars (132)
Biotechnology (44)
Bladder cancer (60)
Brain cancer (34)
Breast cancer (256)
Cancer (2162)
Cardiovascular disease (212)
Career advice (447)
Career pathing (18)
CAR-T (107)
CDC (6)
Cell therapy (316)
Cervical cancer (15)
Clinical research (39689)
Collaboration (1112)
Compensation (344)
Complete response letters (38)
COVID-19 (955)
CRISPR (55)
C-suite (507)
Cystic fibrosis (78)
Data (2781)
Denatured (18)
Depression (73)
Diabetes (207)
Diagnostics (2034)
Digital health (15)
Diversity (3)
Diversity, equity & inclusion (15)
Drug discovery (158)
Drug pricing (117)
Drug shortages (12)
Duchenne muscular dystrophy (140)
Earnings (43673)
Editorial (21)
Employer branding (7)
Employer resources (50)
Events (42909)
Executive appointments (598)
FDA (10690)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (4)
Frontotemporal dementia (14)
Funding (694)
Gene editing (115)
Generative AI (26)
Gene therapy (320)
GLP-1 (558)
Government (1654)
Grass and pollen (5)
Guidances (232)
Healthcare (5091)
HIV (20)
Huntington's disease (22)
IgA nephropathy (57)
Immunology and inflammation (132)
Immuno-oncology (33)
Indications (69)
Infectious disease (1048)
Inflammatory bowel disease (103)
Inflation Reduction Act (7)
Influenza (38)
Intellectual property (164)
Interviews (67)
IPO (7278)
IRA (33)
Job creations (2173)
Job search strategy (393)
JPM (34)
Kidney cancer (9)
Labor market (29)
Layoffs (257)
Leadership (10)
Legal (3593)
Liver cancer (36)
Longevity (9)
Lung cancer (283)
Lymphoma (182)
Machine learning (18)
Management (18)
Manufacturing (526)
MASH (110)
Medical device (3096)
Medtech (3111)
Mergers & acquisitions (11556)
Metabolic disorders (642)
Multiple sclerosis (82)
NASH (17)
Neurodegenerative disease (151)
Neuropsychiatric disorders (52)
Neuroscience (1348)
Neurotech (1)
NextGen: Class of 2026 (1926)
Non-profit (775)
Now hiring (17)
Obesity (302)
Opinion (161)
Ovarian cancer (65)
Pain (142)
Pancreatic cancer (104)
Parkinson's disease (120)
Partnered (13)
Patents (296)
Patient recruitment (340)
Peanut (23)
People (31301)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (11504)
Phase 2 (17047)
Phase 3 (14219)
Pipeline (3393)
Policy (141)
Postmarket research (1434)
Preclinical (4018)
Press Release (30)
Prostate cancer (131)
Psychedelics (21)
Radiopharmaceuticals (169)
Rare diseases (505)
Real estate (2962)
Recruiting (20)
Regulatory (13831)
Reports (19)
Research institute (695)
Resumes & cover letters (59)
Rett syndrome (22)
RNA editing (9)
RSV (31)
Schizophrenia (94)
Series A (126)
Series B (97)
Service/supplier (2)
Sickle cell disease (58)
Special edition (11)
Spinal muscular atrophy (120)
Sponsored (16)
Startups (1869)
State (2)
Stomach cancer (8)
Supply chain (57)
Tariffs (70)
The Weekly (47)
Vaccines (343)
Venture capital (38)
Weight loss (186)
Women's health (40)
Worklife (4)
Date
Today (21)
Last 7 days (268)
Last 30 days (1049)
Last 365 days (15456)
2026 (1529)
2025 (15691)
2024 (17170)
2023 (19024)
2022 (24347)
2021 (24862)
2020 (22804)
2019 (17675)
2018 (13928)
2017 (16221)
2016 (14922)
2015 (17590)
2014 (13904)
2013 (11622)
2012 (12560)
2011 (13031)
2010 (11886)
Location
Africa (343)
Alabama (34)
Alaska (1)
Arizona (106)
Arkansas (4)
Asia (24269)
Australia (3409)
California (5015)
Canada (1875)
China (738)
Colorado (241)
Connecticut (205)
Delaware (166)
Europe (48777)
Florida (818)
Georgia (107)
Hawaii (1)
Idaho (14)
Illinois (417)
India (50)
Indiana (279)
Iowa (5)
Japan (285)
Kansas (82)
Kentucky (20)
Louisiana (4)
Maine (9)
Maryland (663)
Massachusetts (3956)
Michigan (105)
Minnesota (254)
Mississippi (2)
Missouri (59)
Montana (11)
Nebraska (13)
Nevada (43)
New Hampshire (19)
New Jersey (1676)
New Mexico (8)
New York (1409)
North Carolina (811)
North Dakota (5)
Northern California (2344)
Ohio (117)
Oklahoma (11)
Oregon (23)
Pennsylvania (1089)
Puerto Rico (14)
Rhode Island (22)
South America (550)
South Carolina (22)
Southern California (2120)
Tennessee (73)
Texas (721)
United States (18723)
Utah (104)
Virginia (176)
Washington D.C. (47)
Washington State (398)
West Virginia (2)
Wisconsin (55)
Wyoming (2)
323,567 Results for "milestone pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook
January 9, 2026
·
8 min read
Press Releases
ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones
January 13, 2026
·
9 min read
Press Releases
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - February 3, 2026
February 3, 2026
·
1 min read
Press Releases
Milestone Pharmaceuticals Announces Acceptance of Marketing Authorization Application for Etripamil Nasal Spray in PSVT by the European Medicines Agency
January 6, 2026
·
7 min read
Approvals
Milestone’s Long Regulatory Road Ends in Approval for Cardamyst
The FDA had previously turned back the heart rhythm nasal spray twice, once in late 2023 with a refusal to file letter and again in March this year, when it flagged manufacturing issues.
December 15, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Rhythm Pharmaceuticals Announces Preliminary, Unaudited Fourth Quarter and Full Year 2025 Net Product Revenues and Upcoming Milestones
January 9, 2026
·
11 min read
Press Releases
Arrowhead Pharmaceuticals Earns $200 Million Milestone Payment from Sarepta Therapeutics
November 24, 2025
·
4 min read
Press Releases
Zentalis Pharmaceuticals Provides Corporate Update and Highlights Key Milestones and Expected Momentum in the Azenosertib Development Program for 2026
January 6, 2026
·
9 min read
Press Releases
Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference
January 8, 2026
·
7 min read
Press Releases
Milestone Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Regulatory and Corporate Update
November 13, 2025
·
11 min read
1 of 32,357
Next
